December 27, 2023 Comments Off on New patent for Blueprint Medicines drug AYVAKIT Posted in: Patent Added Annual Drug Patent Expirations for AYVAKIT Ayvakit is a drug marketed by Blueprint Medicines and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent for Blueprint Medicines drug AYVAKIT appeared first…
December 23, 2023 Comments Off on New patent for Ucb Inc drug FINTEPLA Posted in: Patent Added Annual Drug Patent Expirations for FINTEPLA Fintepla is a drug marketed by Ucb Inc and is included in one NDA. It is available from one supplier. There are twelve patents…
The post New patent for Ucb Inc drug FINTEPLA appeared first on DrugPatentWatch …